All lobbying filings
THE MCMANUS GROUP
Lobbying for DENDREON PHARMACEUTICALS LLC · Biopharmaceutical company.
Filing
3rd Quarter - Report
Lobbying activity
2
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.
Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.